Editor

DiPiro, Joseph T.

Yee, Gary C.

Posey, L. Michael

Edition

11th ed.

Place of Publication

New York, NY

Publisher

McGraw Hill Medical

Publication Date

2020

Physical Description

xxi, 2635 p. : ill. ; 28 cm.

Subjects

Drug Therapy

Pharmacology, Clinical

ISBN

9781260116816

Language

English

Material Type

Book

Audience

Professional

Location

Abbotsford Library

Call Number

WB330 P536 2020

Copies

Editor

Malviya, Rishabha

Singh, Arun Kumar

Yadav, Deepika

Edition

1st ed.

Place of Publication

Beverly, MA

Publisher

Scrivener Publishing

Publication Date

c2023

Series

Proquest Ebook Central

Subjects

Chemotherapy

Drug Resistance, Neoplasm

Abstract

"The book details the mechanisms underlying multi-drug cellular resistance and the targets of novel chemotherapeutic agents.

Cancer is a major killer all over the world. Even with all the progress made, chemotherapy is still the mainstay of modern cancer treatment. The progression of the cellular defeat of numerous independent anticancer drugs in terms of their chemical structure is a major barrier to successful chemotherapy. Multi-drug resistance (MDR) is a term for the fact that most cancer patients exhibit this phenomenon. According to the numbers, drug resistance carries the blame for 90% of cancer patient deaths. Refractory cancer and tumor recurrence are common outcomes of prolonged chemotherapy. Because of the prevalence of drug-resistance mutations, the difficulty of treating tumors increases and the therapeutic efficacy of drugs decreases.

Multi-Drug Resistance in Cancer: Mechanism and Treatment Strategies contains nine chapters that cover topics such as: studying the mechanics of resistance to drugs by autophagy; studies to delineate the role of efflux transporters; expression of drug transporters; resistance to targeted therapies in breast cancer; advances in metallodrug driven combination treatment for cancer; and use of natural agents for the overcoming of cancer drug resistance.

The book aims to provide the latest data on the mechanisms of cellular resistance to anticancer agents currently used in clinical treatment. It provides a better understanding of the mechanisms of MDR and targets of novel chemotherapy agents which should guide future research concerning new effective strategies in cancer treatment.

Audience

This book is written for pharmaceutical and biomedical scientists and researchers at both the bench and in the clinic who are interested in the mechanisms and strategies for overcoming cancer's multi-drug resistance." --publisher

ISBN

9781394209217

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer-network computers. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Chu, Edward

DeVita Jr., Vincent T.

Edition

22nd ed.

Place of Publication

Burlington, MA

Publisher

Jones & Bartlett Learning

Publication Date

c2023

Series

Proquest Ebook Central

Subjects

Drug Therapy

Pharmacology, Clinical

Neoplasms--drug therapy

Abstract

"Written by world-class experts in clinical cancer therapeutics, Physicians' Cancer Chemotherapy Drug Manual 2022 provides a complete, easy-to-use catalog of over 100 drugs and commonly used drug regimens--both on- and off-label--for the treatment of all the major cancers."--publisher

ISBN

9781284229653

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer-network computers. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Author

Cavalcanti, Iago Dillion Lima

Soares, José Cleberson Santos

Place of Publication

Cham, Switzerland

Publisher

Springer Nature Switzerland AG

Publication Date

2021

Series

Proquest Ebook Central

Subjects

Neoplasms - therapy

Neoplasms - epidemiology

Neoplasms - immunology

Abstract

Summary:

ISBN

9783030683337

9783030683344

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer network computer. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Qazi, Asma Saleem

Tariq, Kanwal

Edition

1st ed.

Place of Publication

Cham, Switzerland

Publisher

Springer International Publishing AG

Publication Date

c2023

Series

Proquest Ebook Central

Subjects

Neoplasms - therapy

Therapeutics

Drug Therapy

Hormones

Radiotherapy

Immunotherapy

Nutrition Assessment

Antineoplastic Agents

Pharmacogenomic Variants

Abstract

"This comprehensive book provides an overview of cancer therapeutics and covers different innovative treatment approaches for cancer. The initial chapter gives a detailed overview on cancer progression and disease diagnostics. The following chapters focus on different cancer treatment approaches, such as chemotherapy, radiotherapy, hormonal therapy, immunotherapy, nutritional assessments, targeted therapy and Nano therapeutics. It also highlights the importance of cancer genomics, disease advancement, personalized medicine and psychological support for cancer patients. Emphasis is also given to the many challenges in the area of designing cancer treatment and designing clinical trials. The complete book also presents cancer management with different cancer treatment modalities, including pharmacogenomics and drug reactions. This is a unique and comprehensive piece of work that not only highlights the disease treatment modalities but also focuses on many challenges in the area of designing cancer treatment and even in designing clinical trials.

The contributing authors are experts in this field of cancer treatment. By familiarizing readers with the latest developments in this complex field, the book offers a valuable resource for clinicians. Researchers and medical students will also benefit from this comprehensive text." --publisher

ISBN

9783031271557

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer-network computers. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Scholefield, Donna

Sebti, Alan

Edition

2nd ed., rev. and updated

Place of Publication

Keswick, Cumbria

Publisher

M&K Publishing

Publication Date

2021

Series

EBSCOhost eBook Nursing Collection

Essentials

Subjects

Pharmacology - nurses' instruction

Nursing

Case Reports

ISBN

9781910451250

9781910451755

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This EBSCO title is licensed for one BC Cancer staff user at a time only. Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Author

Dang, Deborah

Dearholt, Sandra

Bissett, Kim

Corporate Author

Sigma Theta Tau International

Johns Hopkins University. School of Nursing

Edition

4th ed.

Place of Publication

Indianapolis, IN

Publisher

Sigma Theta Tau International

Publication Date

2022

Series

EBSCOhost eBook Nursing Collection

Subjects

Evidence-Based Nursing

Models, Nursing

Evidence-based practice - methods

ISBN

9781948057875

9781948057882

9781948057899

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This EBSCO title is licensed for one BC Cancer staff user at a time only. Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Grossman, Mary

Place of Publication

Cham, Switzerland

Publisher

Springer

Publication Date

2022

Series

Proquest Ebook Central

Subjects

Oncology Nursing

Neoplasms - nursing

Models, Nursing

Nursing Care - methods

ISBN

9783031061004

9783031061011

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer network computer. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Author

Cullen, Laura

Hanrahan, Kirsten

Farrington, Michele

Corporate Author

Sigma Theta Tau International

Edition

2nd ed.

Place of Publication

Indianapolis, IN

Publisher

Sigma Theta Tau International

Publication Date

2022

Series

R2 Library

Subjects

Evidence-Based Nursing - methods

Models, Nursing

University of Iowa Hospitals and Clinics

Abstract

Evidence-based practice (EBP) is a process of shared decision-making between clinicians and patients based on research evidence, the patient's experiences and preferences, and the clinician's clinical expertise. We are now well beyond the Institute of Medicine (IOM) goal that 90% of healthcare be evidence-based by 2020 (IOM, 2010), and a gap persists. The need for EBP is more crucial than ever and must consider value-based care; patient preferences; diversity, equity, and inclusion; regulatory standards; costs; and implementation science. EBP in Action addresses the need for a clear EBP process along with precise, accurate, and effective selection of implementation strategies and resources to promote adoption and sustainability of EBP recommendations. In this book, we will inspire you to use the EBP process, think creatively, and engage patients in EBP co-design for improved outcomes -- Provided by publisher.

ISBN

1948057956

9781948057950

9781948057967

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This R2 title is licensed for one BC Cancer staff user at a time only. Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Baatrup, Gunnar

Edition

2nd ed.

Place of Publication

Cham, Switzerland

Publisher

Springer

Publication Date

2020

Series

Proquest Ebook Central

Subjects

Colorectal Neoplasms - therapy

Patient Care Team

ISBN

9783030588458

9783030588465

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Author

Alon, Uri

Edition

1st ed.

Place of Publication

Boca Raton, FL

Publisher

CRC Press

Publication Date

2024

Physical Description

xi, 255 p. : col. ill. ; 26 cm.

Series

Computational biology series

Subjects

Systems Biology - methods

Models, Theoretical

Endocrine System Diseases - physiopathology

Immune System Diseases - physiopathology

Aging - pathology

Notes

Risk of cancer is briefly mentioned around page 224.

ISBN

9781032411859

Language

English

Material Type

Book

Audience

Professional

Location

Vancouver Library

Call Number

HQ324.2 A454 2024

Copies

Author

Hays, Priya

Edition

1st ed.

Place of Publication

Cham, Switzerland

Publisher

Springer International Publishing AG

Publication Date

c2022

Series

Proquest Ebook Central

Subjects

Hematologic Neoplasms

Neoplasms

Immunotherapy

Abstract

"This book presents the clinical scope of cancer immunotherapeutic agents for solid tumors and Hematologic malignancies, elaborates on the scientific details of their modes of action, and presents the impact of these agents on oncology, patients and the broader healthcare system. At present, cancer immunotherapies fall broadly into three categories: immune checkpoint inhibitors (ICIs), adoptive T cell therapies, and cancer vaccines which have distinct mechanisms of action. Immune checkpoint inhibitors rely upon disrupting tumor antigen recognition as self by the immune system through inhibition of checkpoint molecules. Adoptive T cell therapies involve the engineering of T cells ex vivo to target and destroy tumor cells.

The first part of this book will provide an overview of the discovery and mechanistic details of the technology. The second part will be devoted to elaborating on the clinical outcomes, successes and limitations for specific tumor subtypes, which includes both solid tumors and hematologic malignances for both pediatric and adult populations. As such, the book offers a valuable resource for oncologists, hematologists, and all those seeking an up-to-date overview of cancer immunotherapies." --publisher

ISBN

9783030963750

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer-network computers. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Abutalib, Syed A.

Markman, Maurie

Edition

2nd ed.

Place of Publication

Hoboken, NJ

Publisher

John Wiley & Sons, Inc.

Publication Date

2024

Series

Proquest Ebook Central

Subjects

Neoplasms - therapy

Examination Questions

ISBN

9781119823735

9781119823742

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Alternate Title

Primer of the molecular biology of cancer.

Editor

DeVita, Vincent T., Jr.

Lawrence, Theodore S.

Rosenberg, Steven A.

Edition

3rd ed.

Place of Publication

Philadelphia, PA

Publisher

Lippincott Williams & Wilkins

Publication Date

2021

Series

R2 Library

Subjects

Neoplasms - etiology

Neoplasms - genetics

Neoplasms - physiopathology

Molecular Biology - methods

Abstract

"This title will help you understand and apply the scientific advances that are revolutionizing cancer research and practice with Cancer: Principles and Practice of Oncology: Primer of the Molecular Biology of Cancer. Derived from DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology - widely hailed as the definitive clinical reference in oncology - the third edition of this popular Primer focuses on the molecular biology information that is of critical importance to research scientists and clinical oncologists alike. Get up-to-date, dependable coverage of every important frontier in aspect of the molecular biology of cancer with contributions from a noteworthy roster of leading scientists and clinicians. See how molecular biology advances are impacting clinical practice with separate chapters on each of the 19 most common cancer types. Navigate the challenges and ethical dilemmas of cancer genetics with a thorough section chapters on genetic counseling and genetic testing"-- Provided by publisher.

ISBN

9781975149116

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This R2 title is licensed for one BC Cancer staff user at a time only. Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Corporate Author

International Agency for Research on Cancer

World Health Organization

Editor

WHO Classification of Tumours Editorial Board

Edition

5th ed.

Place of Publication

Lyon, France

Publisher

International Agency for Research on Cancer

Publication Date

2021

Series

World Health Organization classification of tumours,

IARC WHO classification of tumours

Subjects

Thoracic Neoplasms

ISBN

9789283245063

Language

English

Material Type

Book

Audience

Professional

Location

Vancouver Library

Call Number

WJ160 T487 2021

Copies

Alternate Title

WHO classification of female genital tumours

World Health Organization classification female genital tumours

WHO classification of tumours : female genital tumours

Female genital tumors

Corporate Author

International Agency for Research on Cancer

World Health Organization

Editor

WHO Classification of Tumours Editorial Board

Edition

5th ed.

Place of Publication

Lyon, France

Publisher

International Agency for Research on Cancer

Publication Date

2020

Physical Description

xii, 632 p. : ill., maps (some color) ; 27 cm

Series

World Health Organization classification of tumours, vol 4.

IARC WHO classification of tumours

Subjects

Genital Neoplasms, Female - classification

Genital Neoplasms, Female - genetics

Genital Neoplasms, Female - pathology

Notes

"The WHO classification of female genital tumours presented in this book reflects the views of the WHO Classification of Tumours Editorial Board that convened at the International Agency for Research on Cancer, Lyon, France, 7-9 October 2019."--page [iii].

Preceded by: WHO classification of tumours of female reproductive organs. 4th ed. (International Agency for Research on Cancer , 2014)

ISBN

9789283245049

Language

English

Material Type

Book

Audience

Professional

Location

Vancouver Library

Call Number

WP145 W628 2020

Copies

Editor

Lee, Daniel W.

Shah, Nirali N.

Place of Publication

Cambridge, MA

Publisher

Elsevier, Inc.

Publication Date

2020

Physical Description

xiv, 229 p. : ill. ; 24 cm.

Subjects

Neoplasms - therapy

Receptors, Chimeric Antigen - therapeutic use

Receptors, Antigen, T-Cell

Immunotherapy, Adoptive - methods

Cell- and Tissue-Based Therapy

Abstract

Contents:

Introduction -- When to refer a patient for CAR-T cell therapy -- Optimizing the apheresis product -- CAR T cells: cell processing laboratory considerations -- Peri-CAR-T cell management -- Management of cytokine release syndrome -- Special considerations for ICU management of patients receiving CAR therapy -- Neurotoxicities after CAR-T cell immunotherapy -- Hematologic and non-CRS toxicities -- Response assessment and post-CAR-T cell therapy management -- Relapse management and role for consolidative hematopoietic stem cell transplantation following CAR-T cell therapy -- Promising chimeric antigen receptors for non-B cell hematological malignancies, pediatric solid tumors, and carcinomas -- CAR T cell therapy for CNS malignancies -- CAR 2.0: the next generation of synthetic receptor-based cellular therapy for cancer.

ISBN

9780323661812

Language

English

Material Type

Book

Audience

Professional

Location

Vancouver Library

Abbotsford Library

Victoria Library

Call Number

QZ266 C538 2020

Copies

Corporate Author

International Agency for Research on Cancer

World Health Organization

Editor

WHO Classification of Tumours Editorial Board

Edition

5th ed.

Place of Publication

Lyon, France

Publisher

International Agency for Research on Cancer

Publication Date

2021

Physical Description

xiii, 568 p. : ill. ; 27 cm

Series

World Health Organization classification of tumours,

IARC WHO classification of tumours

Subjects

Central Nervous System Neoplasms

Central Nervous System Neoplasms - classification

ISBN

9789283245087

Language

English

Material Type

Book

Audience

Professional

Location

Vancouver Library

Call Number

WL15 W628 2021

Copies

Alternate Title

WHO classification of soft tissue and bone tumours

World Health Organization classification soft tissue and bone tumours

WHO classification of tumours : soft tissue and bone tumours

Soft tissue and bone tumors

Corporate Author

International Agency for Research on Cancer

World Health Organization

Editor

WHO Classification of Tumours Editorial Board

Edition

5th ed.

Place of Publication

Lyon, France

Publisher

International Agency for Research on Cancer

Publication Date

2020

Physical Description

x, 607 p. : ill. (chiefly col.) ; 27 cm

Series

World Health Organization classification of tumours, Vol. 3

IARC WHO classification of tumours

Subjects

Soft Tissue Neoplasms - genetics

Soft Tissue Neoplasms - pathology

Soft Tissue Neoplasms - classification

Bone Neoplasms - genetics

Bone Neoplasms - pathology

Bone Neoplasms - classification

Neoplasms, Connective and Soft Tissue - genetics

Neoplasms, Connective and Soft Tissue - pathology

Neoplasms, Connective and Soft Tissue - classification

Sarcoma - genetics

Sarcoma - pathology

Abstract

The WHO classification of soft tissue and bone tumours presented in this book reflects the view of the WHO Classification of Tumours Editorial Board that convened at the International Agency for Research on Cancer, Lyon, France, 6-8 May 2019. -- page [iii]

ISBN

9789283245025

Language

English

Material Type

Book

Audience

Professional

Location

Vancouver Library

Call Number

QZ340 W927 2020

Copies

Author

Tedder, Emma Jean

Place of Publication

New York, NY

Publisher

Routledge

Publication Date

[2021]

Series

Proquest Ebook Central

Subjects

Neoplasms.

Women

Women's Health Services

Poverty

Socioeconomic Factor

Notes

First published in 1998 by Haworth Press

ISBN

9781000524178

9781032166261

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.